Publicaciones (30) Publicaciones de Fernando Isidro Montón Álvarez

2023

  1. Quality of life and mental health in young strokes

    Neurologia

2022

  1. Clinical and genetic features of a large homogeneous cohort of oculopharyngeal muscular dystrophy patients from the Canary Islands

    European Journal of Neurology, Vol. 29, Núm. 5, pp. 1488-1495

2021

  1. Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C

    Journal of Clinical Endocrinology and Metabolism, Vol. 106, Núm. 2, pp. E660-E674

  2. Longitudinal Study of Cognitive Functioning in Friedreich's Ataxia

    Journal of the International Neuropsychological Society, Vol. 27, Núm. 4, pp. 343-350

2020

  1. Expanding the phenotypic and molecular spectrum of RNA polymerase III-related leukodystrophy

    Neurology: Genetics, Vol. 6, Núm. 3

  2. Health-related quality of life and depressive symptoms in Friedreich ataxia

    Quality of Life Research, Vol. 29, Núm. 2, pp. 413-420

2019

  1. Cognitive characterization of SCAR10 caused by a homozygous c.132dupA mutation in the ANO10 gene

    Neurocase, Vol. 25, Núm. 5, pp. 195-201

2018

  1. Depressive symptoms in Friedreich ataxia

    International journal of clinical and health psychology, Vol. 18, Núm. 1, pp. 18-26

2017

  1. Corrigendum to “External conditions inversely change the RNA polymerase II elongation rate and density in yeast” [Biochim. Biophys. Acta (2013) 1829(11) (1248–1255)] (S1874939913001417)(10.1016/j.bbagrm.2013.09.008)

    Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

2013

  1. A Cocoa Peptide Protects Caenorhabditis elegans from Oxidative Stress and β-Amyloid Peptide Toxicity

    PLoS ONE, Vol. 8, Núm. 5

  2. Cognition in late-onset friedreich ataxia

    Cerebellum, Vol. 12, Núm. 4, pp. 504-512

  3. External conditions inversely change the RNA polymerase II elongation rate and density in yeast

    Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, Vol. 1829, Núm. 11, pp. 1248-1255

2012

  1. Caenorhabditis elegans as a model to study the effectiveness and metabolic targets of dietary supplements used for obesity treatment: The specific case of a conjugated linoleic acid mixture (Tonalin)

    Journal of Agricultural and Food Chemistry, Vol. 60, Núm. 44, pp. 11071-11079

  2. Cognition in friedreich ataxia

    Cerebellum, Vol. 11, Núm. 4, pp. 834-844

2011

  1. Use of Saccharomyces cerevisiae and Caenorhabditis elegans as model organisms to study the effect of cocoa polyphenols in the resistance to oxidative stress

    Journal of Agricultural and Food Chemistry, Vol. 59, Núm. 5, pp. 2077-2085

2010

  1. Idebenone: A guide to its use in Alzheimers disease, other age-related cognitive disorders and Friedreichs ataxia

    Drugs and Therapy Perspectives

2009

  1. Effectiveness and safety of treatments for degenerative ataxias: A systematic review

    Movement Disorders, Vol. 24, Núm. 8, pp. 1111-1124

2008

  1. Lack of association of endothelial nitric oxide synthase polymorphisms and migraine

    Headache, Vol. 48, Núm. 7, pp. 1115-1119

  2. Multilocus analyses reveal involvement of the ESR1, ESR2, and FSHR genes in migraine

    Headache, Vol. 48, Núm. 10, pp. 1438-1450

  3. SUNCT and trigeminal neuralgia attributed to meningoencephalitis

    Journal of Headache and Pain, Vol. 9, Núm. 1, pp. 51-53